Literature DB >> 18468402

Investigation of ABCA1 C69T and G-191C polymorphisms in coronary artery disease.

Arzu Ergen1, Selim Isbir, Atike Tekeli, Turgay Isbir.   

Abstract

BACKGROUND: Defects of lipoprotein metabolism are common risk factors for coronary artery disease. The ATP binding cassette transporter 1 (ABCA1) plays an important role in carrying cholesterol from peripheral tissues to the liver. The role of ABCA1 C69T and G-191C gene polymorphisms on plasma lipid levels of patients with coronary artery disease was investigated. PATIENTS AND METHODS: Seventy-seven patients with coronary artery disease and fifty healthy controls were studied. Gene polymorphisms were determined by polymerase chain reaction-restriction fragment length polymorphism method.
RESULTS: No differences in the distribution of C69T and G-191C polymorphisms were observed in the study groups. Plasma triacylglycerol and VLDL-cholesterol levels were shown to be higher in the patient group with the C69T CC genotype compared to these patients with the CT genotype. The C69T polymorphism was associated with HDL-cholesterol levels, which insignificantly increased in the order of the CC>CT>TT genotypes in our study. No association was found between G-191C genotype and lipid levels.
CONCLUSION: The results of our study suggested that polymorphisms of ABCA1 C69T polymorphism may be associated with plasma triacylglycerol and VLDL-cholesterol levels in coronary artery patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18468402

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  7 in total

1.  ABCA1 C69T gene polymorphism and risk of type 2 diabetes mellitus in a Saudi population.

Authors:  Khalid K Alharbi; Imran Ali Khan; Nasser M Al-Daghri; Anjana Munshi; Vandana Sharma; Abdul Khader Mohammed; Kaiser A Wani; Yazeed A Al-Sheikh; May Salem Al-Nbaheen; Mohammed Ghouse Ahmed Ansari; Rabbani Syed
Journal:  J Biosci       Date:  2013-12       Impact factor: 1.826

2.  Investigation of ABCA1 C69T polymorphism in patients with type 2 diabetes mellitus.

Authors:  H Arzu Ergen; Umit Zeybek; Ozlem Gök; Z Ermis Karaali
Journal:  Biochem Med (Zagreb)       Date:  2012       Impact factor: 2.313

3.  Association between Polymorphisms and Haplotype in the ABCA1 Gene and Overweight/Obesity Patients in the Uyghur Population of China.

Authors:  Ming-Hong Yao; Jia He; Ru-Lin Ma; Yu-Song Ding; Heng Guo; Yi-Zhong Yan; Jing-Yu Zhang; Jia-Ming Liu; Mei Zhang; Dong-Shen Rui; Qiang Niu; Shu-Xia Guo
Journal:  Int J Environ Res Public Health       Date:  2016-02-15       Impact factor: 3.390

4.  ABCA1 69C>T Polymorphism and the Risk of Type 2 Diabetes Mellitus: A Systematic Review and Updated Meta-Analysis.

Authors:  Ha Young Yoon; Min Hye Lee; Yubin Song; Jeong Yee; Gonjin Song; Hye Sun Gwak
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-23       Impact factor: 5.555

5.  Association of ATP-Binding Cassette Transporter A1 Gene Polymorphisms in Type 2 Diabetes Mellitus among Malaysians.

Authors:  Polin Haghvirdizadeh; Vasudevan Ramachandran; Ali Etemad; Farzad Heidari; Nooshin Ghodsian; Norzian Bin Ismail; Patimah Ismail
Journal:  J Diabetes Res       Date:  2015-09-14       Impact factor: 4.011

6.  Interactions of Six SNPs in ABCA1gene and Obesity in Low HDL-C Disease in Kazakh of China.

Authors:  Ming-hong Yao; Heng Guo; Jia He; Yi-zhong Yan; Ru-lin Ma; Yu-song Ding; Jing-yu Zhang; Jia-ming Liu; Mei Zhang; Shu-gang Li; Shang-zhi Xu; Qiang Niu; Jiao-long Ma; Shu-xia Guo
Journal:  Int J Environ Res Public Health       Date:  2016-01-28       Impact factor: 3.390

7.  Interactions among genes involved in reverse cholesterol transport and in the response to environmental factors in dyslipidemia in subjects from the Xinjiang rural area.

Authors:  Xinping Wang; Heng Guo; Yu Li; Haixia Wang; Jia He; Lati Mu; Yunhua Hu; Jiaolong Ma; Yizhong Yan; Shugang Li; Yusong Ding; Mei Zhang; Qiang Niu; Jiaming Liu; Jingyu Zhang; Rulin Ma; Shuxia Guo
Journal:  PLoS One       Date:  2018-05-14       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.